Syndax Pharmaceuticals, Inc. (SNDX) Insider Trading

Over the last 3 months, SNDX insiders made 0 open-market buys and 5 sales, a net sale of -$2.1M (SEC Form 4). Over the last 6 months, 194 institutions increased and 152 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
5
Net (3m)
-$2.1M
Insider trades by month Buys Sells
Jul
Aug
Sep
Feb
Jun
Jul
Context3-month price +0.4%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jul 9, 2026Metzger Michael Adirector, officer: Chief Executive OfficerSell32,375$24.24
Jul 9, 2026Metzger Michael Adirector, officer: Chief Executive OfficerOption32,375$6.38
Jun 12, 2026Botwood Nicholas A.J.officer: Head of R&D, CMOSell34,280$18.00
Jun 12, 2026Botwood Nicholas A.J.officer: Head of R&D, CMOOption22,515$13.82
Jun 12, 2026Botwood Nicholas A.J.officer: Head of R&D, CMOSell31,235$18.14
Jun 12, 2026Botwood Nicholas A.J.officer: Head of R&D, CMOOption31,235$13.82
Jun 2, 2026Goldan Keith A.officer: Chief Financial OfficerSell1,177$18.99
Jun 2, 2026Metzger Michael Adirector, officer: Chief Executive OfficerSell6,847$18.99
Feb 10, 2026Goldan Keith A.officer: Chief Financial OfficerSell3,410$21.03
Feb 10, 2026Metzger Michael Adirector, officer: Chief Executive OfficerSell17,159$21.03
Feb 6, 2026Goldan Keith A.officer: Chief Financial OfficerGrant118,000$20.43
Feb 6, 2026Goldan Keith A.officer: Chief Financial OfficerGrant21,500
Feb 6, 2026Jarrett JenniferdirectorGrant24,000
Feb 6, 2026Huber Martin H. Jr.directorGrant24,000
Feb 6, 2026Botwood Nicholas A.J.officer: Head of R&D, CMOGrant144,700$20.43
Feb 6, 2026Botwood Nicholas A.J.officer: Head of R&D, CMOGrant36,000
Feb 6, 2026Botwood Nicholas A.J.officer: Head of R&D, CMOGrant24,000
Feb 6, 2026Metzger Michael Adirector, officer: Chief Executive OfficerGrant73,000
Feb 6, 2026Rizo AleksandradirectorGrant24,000
Feb 6, 2026Metzger Michael Adirector, officer: Chief Executive OfficerGrant144,600
Feb 6, 2026Metzger Michael Adirector, officer: Chief Executive OfficerSell7,412$20.62
Feb 6, 2026Legault PierredirectorGrant24,000
Feb 6, 2026Metzger Michael Adirector, officer: Chief Executive OfficerGrant440,000$20.43
Feb 6, 2026Katkin KeithdirectorGrant24,000
Feb 6, 2026Podlesak DennisdirectorGrant48,000
Feb 6, 2026Goldan Keith A.officer: Chief Financial OfficerGrant30,750
Feb 6, 2026Goldan Keith A.officer: Chief Financial OfficerSell2,082$20.62
Sep 8, 2025Metzger Michael Adirector, officer: Chief Executive OfficerSell157,307$16.41
Sep 8, 2025Metzger Michael Adirector, officer: Chief Executive OfficerOption157,307$10.90
Aug 18, 2025Podlesak DennisdirectorSell19,200$14.19

Source: SNDX SEC Form 4 filings, latest Jul 9, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their SNDX positions over the last 6 months (SEC Form 13F).

Increased
194
New positions
81
Reduced
152
Sold out
39
Largest moves
InstitutionActionSharesFiled
BlackRock, Inc.Increased9.0MAug 7, 2026
BLACKROCK, INC.Increased8.3MMay 13, 2026
Kynam Capital Management, LPUnchanged8.1MAug 14, 2026
KYNAM CAPITAL MANAGEMENT, LPUnchanged8.1MMay 15, 2026
GOLDMAN SACHS GROUP INCIncreased5.9MAug 14, 2026
GOLDMAN SACHS GROUP INCIncreased5.7MMar 25, 2026
STATE STREET CORPIncreased5.7MAug 7, 2026
GOLDMAN SACHS GROUP INCReduced5.0MMay 15, 2026
STATE STREET CORPReduced4.4MMay 15, 2026
BANK OF AMERICA CORP /DE/Reduced4.2MMay 18, 2026
BANK OF AMERICA CORP /DE/Reduced4.0MAug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased3.9MAug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position3.8MMay 15, 2026
DEERFIELD MANAGEMENT COMPANY, L.P.Unchanged3.8MAug 14, 2026
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)New Position3.8MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.